Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjögren’s syndrome

REFERENCES

• Fox RI. Sjögren's syndrome. Lancet. 2005;366:321–31.
   PubMed Web of Science ®Google Scholar
• Aasarod K, Haga HJ, Berg KJ, Hammerstrom J, Jorstad S. Renal involvement in primary Sjögren's syndrome. QJM. 2000;93: 297–304.
   Google Scholar
• Pertovaara M, Korpela M, Pasternack A. Factors predictive of renal involvement in patients with primary Sjögren's syndrome. Clin Nephrol. 2001;56:10–8.
   Google Scholar
• Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M, Cavazzana I, et al. Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. Nephrol Dial Transplant. 2001;16:2328–36.
   PubMed Web of Science ®Google Scholar
• Ren H, Wang WM, Chen XN, Zhang W, Pan XX, Wang XL, et al. Renal involvement and followup of 130 patients with pri-mary Sjögren's syndrome. J Rheumatol. 2008;35:278–84.
   PubMed Web of Science ®Google Scholar
• Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, et al. Renal involvement in primary Sjögren's syn-drome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009; 4:1423–31.
   PubMed Web of Science ®Google Scholar
• Lin DF, Yan SM, Zhao Y, Zhang W, Li MT, Zeng XF, et al. Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome. Chin Med J. 2010;123:3252–7.
   PubMed Web of Science ®Google Scholar
• Gaarder PI, Heier HE. A human autoantibody to renal collecting duct cells associated with thyroid and gastric autoimmunity and possibly renal tubular acidosis. Clin Exp Immunol. 1983;51: 29–37.
   PubMedGoogle Scholar
• Cohen EP, Bastani B, Cohen MR, Kolner S, Hemken P, Gluck SL. Absence of H(+)-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis. J Am Soc Nephrol. 1992;3:264–71.
   PubMed Web of Science ®Google Scholar
• DeFranco PE, Haragsim L, Schmitz PG, Bastani B. Absence of vacuolar H(+)-ATPase pump in the collecting duct of a patientwith hypokalemic distal renal tubular acidosis and Sjogren's syndrome. J Am Soc Nephrol. 1995;6:295–301.
   PubMed Web of Science ®Google Scholar
• Han JS, Kim GH, Kim J, Jeon US, Joo KW, Na KY, et al. Secretory-defect distal renal tubular acidosis is associated with transporter defect in H(+)-ATPase and anion exchanger-1. J Am Soc Nephrol. 2002;13:1425–32.
   PubMed Web of Science ®Google Scholar
• Takemoto F, Hoshino J, Sawa N, Tamura Y, Tagami T, YokotaM, et al. Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syn-drome. Am J Med. 2005;118:181–4.
   PubMed Web of Science ®Google Scholar
• Takemoto F, Katori H, Sawa N, Hoshino J, Suwabe T, Sogawa Y, et al. Induction of anti-carbonic-anhydrase-II antibody causes renal tubular acidosis in a mouse model of Sjogren's syndrome. Nephron Physiol. 2007;106:63–8.
   Google Scholar
• Pertovaara M, Bootorabi F, Kuuslahti M, Pastemack A, Parkkila S. Novel carbonic anhydrase autoantibodies and renal manifes-tations in patients with primary Sjogren's syndrome. Rheuma-tology. 2011;50:1453–7.
   Google Scholar
• Okada M, Suzuki K, Hidaka T, Shinohara T, Kataharada K, Matsumoto M, et al. Rapid improvement of osteomalacia by treatment in a case with Sjogren's syndrome, rheumatoid arthritis and renal tubular acidosis type 1. Intern Med. 2001;40:829–32.
   PubMedGoogle Scholar
• Fulop M, Mackay M. Renal tubular acidosis, Sjögren syndrome, and bone disease. Arch Intern Med. 2004;164:905–9.
   PubMedGoogle Scholar
• Arnett TR. Extracellular pH regulates bone cell function. J Nutr. 2008;138:415s–8s.
   Google Scholar
• Domrongkitchaipom S, Pongsakul C, Stitchantrakul W, Siri-kulchayanonta V, Ongphiphadhanakul B, Radinahamed P, et al. Bone mineral density and histology in distal renal tubular aci-dosis. Kidney Int. 2001;59:1086–93.
   Google Scholar
• Domrongkitchaipom S, Pongskul C, Sirikulchayanonta V, Stitchantrakul W, Leeprasert V, Ongphiphadhanakul B, et al. Bone histology and bone mineral density after correction ofacidosis in distal renal tubular acidosis. Kidney Int. 2002;62: 2160–6.
   PubMedGoogle Scholar
• Disthabanchong S, Domrongkitchaipom S, Sirikulchayanonta V, Stitchantrakul W, Karnsombut P, Rajatanavin R. Alteration of noncollagenous bone matrix proteins in distal renal tubular aci-dosis. Bone. 2004;35:604–13.
   PubMedGoogle Scholar
• Laing CM, Unwin RJ. Renal tubular acidosis. J Nephrol. 2006; 19(Suppl 9):546–52.
   Google Scholar
• Saeki Y, Ohshima S, Ishida T, Shima Y, Umeshita-Sasai M, Nishioka K, et al. Remission of the renal involvement in a patient with primary Sjogren's syndrome (SS) after pulse high-dose corticosteroid infusion therapy. Clin Rheumatol. 2001;20:225–8.
   Google Scholar
• Miyawaki S, Nishiyama S, Matoba K. Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjogren's syndrome. Intern Med. 1999;38:938–43.
   Google Scholar
• Matsumura R, Umemiya K, Kagami M, Tomioka H, Tanabe E, Sugiyama T, et al. Glandular and extraglandular expression of the Fos-Fos ligand and apoptosis in patients with Sjogren's syn-drome. Clin Exp Rheumatol. 1998;16:561–8.
   PubMedGoogle Scholar
• Saoud B, Bahiri R, Benbouazza K, Bzami F, Guedira N, Hajjaj-Hassouni N. Osteomalacia revealing Sjogren's syndrome. Joint Bone Spine. 2005;72:594–5.
   PubMedGoogle Scholar
• Kawashima M, Amano T, Morita Y, Yamamura M, Makino H. Hypokalemic paralysis and osteomalacia secondary to renal tubular acidosis in a case with primary Sjogren's syndrome. Mod Rheumatol. 2006;16:48–51.
   Google Scholar
• Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fuku-naga M, et al. Subcommittee to study diagnostic criteria for glucocorticoid-induced osteoporosis. Guidelines on the manage-ment and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab. 2005;23: 105–9.
   Google Scholar